Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes

Cellular Signalling

Volumn 28, Issue 2, 2016, Pages 1-6

  Mali, Vishal R ^a   Deshpande, Mandar ^a   Pan, Guodong ^a   Thandavarayan, Rajarajan A ^b   Palaniyandi, Suresh S ^a,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 Hydroxy 2 nonenal; Aldehyde dehydrogenase 2; Cell death; H9C2 cardiomyocytes; Mitochondrial respiration; Mitochondrial respiratory reserve capacity

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; DISULFIRAM; SMALL INTERFERING RNA; 4-HYDROXY-2-NONENAL; ALDEHYDE; DNA ADDUCT;

ARTICLE; CARDIOTOXICITY; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART CELL CULTURE; HEART MUSCLE CELL; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL RESPIRATORY RESERVE CAPACITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; CELL RESPIRATION; DNA ADDUCT; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MITOCHONDRION; RAT;

ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL; ALDEHYDES; ANIMALS; CELL DEATH; CELL LINE; CELL RESPIRATION; DISULFIRAM; DNA ADDUCTS; MITOCHONDRIA; MYOCYTES, CARDIAC; RATS;

EID: 84947737908     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.11.006     Document Type: Article

References (41)

1. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid. Redox Signal. 2011, 15:1911-1926.
2. Pashkow F.J. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?. Int. J. Inflamm. 2011, 2011:514623.
3. Penckofer S., Schwertz D., Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J. Cardiovasc. Nurs. 2002, 16:68-85.
4. Apel K., Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol. 2004, 55:373-399.
5. Mali V.R., Palaniyandi S.S. Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease. Free Radic. Res. 2014, 48:251-263.
6. Mali V.R., Ning R., Chen J., Yang X.P., Xu J., Palaniyandi S.S. Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin. Exp. Biol. Med. (Maywood) 2014, 239:610-618.
7. Poli G., Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000, 50:315-321.
8. Sies H. Oxidative stress: oxidants and antioxidants. Exp. Physiol. 1997, 82:291-295.
9. Blasig I.E., Grune T., Schonheit K., Rohde E., Jakstadt M., Haseloff R.F., et al. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am. J. Physiol. 1995, 269:H14-H22.
10. Chen J., Henderson G.I., Freeman G.L. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J. Mol. Cell. Cardiol. 2001, 33:1919-1927.
11. Furfaro A.L., Menini S., Patriarca S., Pesce C., Odetti P., Cottalasso D., et al. HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin. Biofactors 2005, 24:291-298.
12. Grune T., Davies K.J. The proteasomal system and HNE-modified proteins. Mol. Asp. Med. 2003, 24:195-204.
13. Hill B.G., Dranka B.P., Zou L., Chatham J.C., Darley-Usmar V.M. Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem. J. 2009, 424:99-107.
14. Lee J.Y., Jung G.Y., Heo H.J., Yun M.R., Park J.Y., Bae S.S., et al. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol. Lett. 2006, 166:212-221.
15. Patel V.B., Spencer C.H., Young T.A., Lively M.O., Cunningham C.C. Effects of 4-hydroxynonenal on mitochondrial 3-hydroxy-3-methylglutaryl (HMG-CoA) synthase. Free Radic. Biol. Med. 2007, 43:1499-1507.
16. VanWinkle W.B., Snuggs M., Miller J.C., Buja L.M. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal. Cell Motil. Cytoskeleton 1994, 28:119-134.
17. Dodson M., Liang Q., Johnson M.S., Redmann M., Fineberg N., Darley-Usmar V.M., et al. Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells. Autophagy 2013, 9:1996-2008.
18. Singh I.N., Gilmer L.K., Miller D.M., Cebak J.E., Wang J.A., Hall E.D. Phenelzine mitochondrial functional preservation and neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4-hydroxy-2-nonenal. J. Cereb. Blood Flow Metab. 2013, 33:593-599.
19. Vladykovskaya E., Sithu S.D., Haberzettl P., Wickramasinghe N.S., Merchant M.L., Hill B.G., et al. Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress. J. Biol. Chem. 2012, 287:11398-11409.
20. Campos J.C., Queliconi B.B., Dourado P.M., Cunha T.F., Zambelli V.O., Bechara L.R., et al. Exercise training restores cardiac protein quality control in heart failure. PLoS ONE 2012, 7.
21. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 1999, 274:23787-23793.
22. Calamaras T.D., Lee C., Lan F., Ido Y., Siwik D.A., Colucci W.S. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling. Free Radic. Biol. Med. 2015, 82:137-146.
23. Budas G.R., Disatnik M.H., Mochly-Rosen D. Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?. Trends Cardiovasc. Med. 2009, 19:158-164.
24. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science (New York, N.Y.) 2008, 321:1493-1495.
25. Zhang Y., Babcock S.A., Hu N., Maris J.R., Wang H., Ren J. Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3beta and mitochondrial function. BMC Med. 2012, 10:40.
26. Wang J., Wang H., Hao P., Xue L., Wei S., Zhang Y., et al. Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats. Mol. Med. 2011, 17:172-179.
27. Mali V.R.N.R., Chen J., Xu J., Yang X.P., Palaniyandi S.S. Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin. Exp. Biol. Med. 2014.
28. Watkins S.J., Borthwick G.M., Arthur H.M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell. Dev. Biol. Anim. 2011, 47:125-131.
29. Stuck B.J., Lenski M., Bohm M., Laufs U. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase. J. Biol. Chem. 2008, 283:32562-32569.
30. Tan X., Wang D.B., Lu X., Wei H., Zhu R., Zhu S.S., et al. Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A. Biol. Pharm. Bull. 2010, 33:1666-1672.
31. Selvakumar D., Drescher M.J., Dowdall J.R., Khan K.M., Hatfield J.S., Ramakrishnan N.A., et al. CNGA3 is expressed in inner ear hair cells and binds to an intracellular C-terminus domain of EMILIN1. Biochem. J. 2012, 443:463-476.
32. Palaniyandi S.S., Nagai Y., Watanabe K., Ma M., Veeraveedu P.T., Prakash P., et al. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats. Exp. Biol. Med. (Maywood) 2007, 232:1213-1221.
33. Kimes B.W., Brandt B.L. Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 1976, 98:367-381.
34. Zhou Y., Jiang Y., Kang Y.J. Copper inhibition of hydrogen peroxide-induced hypertrophy in embryonic rat cardiac H9c2 cells. Exp. Biol. Med. (Maywood) 2007, 232:385-389.
35. Huang C.Y., Chueh P.J., Tseng C.T., Liu K.Y., Tsai H.Y., Kuo W.W., et al. ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells. Biochem. Biophys. Res. Commun. 2004, 324:973-980.
36. Vindis C., D'Angelo R., Mucher E., Negre-Salvayre A., Parini A., Mialet-Perez J. Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors. Biochem. Biophys. Res. Commun. 2010, 391:979-983.
37. Shen M.L., Lipsky J.J., Naylor S. Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase. Biochem. Pharmacol. 2000, 60:947-953.
38. Sansbury B.E., Jones S.P., Riggs D.W., Darley-Usmar V.M., Hill B.G. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem. Biol. Interact. 2011, 191:288-295.
39. Koppaka V., Thompson D.C., Chen Y., Ellermann M., Nicolaou K.C., Juvonen R.O., et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol. Rev. 2012, 64:520-539.
40. Ningaraj N.S., Rao M.K. Disulfiram augments oxidative stress in rat brain following bilateral carotid artery occlusion. J. Biomed. Sci. 1998, 5:226-230.
41. Lashin O.M., Szweda P.A., Szweda L.I., Romani A.M. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radic. Biol. Med. 2006, 40:886-896.